Vimarsana
Biggest News Aggregation in the World

Enhanced Permeability News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Enhanced Permeability. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Enhanced Permeability Today - Breaking & Trending Today

Spago Nanomedical : Annual Report2023 - MarketScreener - Vimarsana News

Spago Nanomedical : Annual Report2023 - MarketScreener

Nanomedicine for ANNUAL...

Discovering New Ways to Boost Nanoparticle Delivery to Tumors - Vimarsana News

Discovering New Ways to Boost Nanoparticle Delivery to Tumors

Prof. Yucai Wang and Assoc. Prof. Wei Jiang, leading a research team at the University of Science and Technology of China (USTC) within the Chinese Academy of Sciences (CAS), has unveiled the previously unknown mechanism of how tumor vascular basement membranes obstruct nanoparticles (NPs).

New Theory Explains How Nanoparticles Enter and Exit the Tumors - Vimarsana News

New Theory Explains How Nanoparticles Enter and Exit the Tumors

At the University of Toronto, scientists have come up with a new theory to describe how nanoparticles enter and exit the tumors they are intended to treat.

Spago Nanomedical Interim Report January-September 2022 - Vimarsana News

Spago Nanomedical Interim Report January-September 2022

LUND, SWEDEN / ACCESSWIRE / November 8, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)Intensive preparations to bring Tumorad into clinicJULY -SEPTEMBER IN BRIEF· Net sales for the quarter amounted

Frontiers | Aspirin Repurposing in Folate-Decorated Nanoparticles: Another Way to Target Breast Cancer - Vimarsana News

Frontiers | Aspirin Repurposing in Folate-Decorated Nanoparticles: Another Way to Target Breast Cancer

Breast cancer affects more than one million women per year worldwide. Through this study, we develop a nanoparticle-based drug delivery system to target breast cancer cells. Aspirin has been found to inhibit thromboembolic diseases with its tumor-preventing activity. As a consequence, it relieves disease symptoms and severity. Here, mesoporous Silica Nanoparticles (MNP) have been used to deliver Aspirin to the tumor location. MNP-based Aspirin in folic acid (F)-conjugated Polydopamine (MNP-Asp-PD-PG-F) vehicles are prepared for targeted breast cancer therapy. The vehicle hinges on MNP altered ...